These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20686151)

  • 1. Levodopa addiction and factitious disorder in a patient with idiopathic Parkinson's disease.
    Zaharna M; Pandya M
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352g.e11-352.e12. PubMed ID: 20686151
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine dysregulation syndrome in Parkinson's disease: case report.
    Kummer A; Maia DP; Salgado JV; Cardoso FE; Teixeira AL
    Arq Neuropsiquiatr; 2006 Dec; 64(4):1019-22. PubMed ID: 17221016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction as aberrant learning-evidence from Parkinson's disease.
    Dagher A
    Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
    [No Abstract]   [Full Text] [Related]  

  • 4. Case study: cerebrovascular parkinsonism with levodopa addiction.
    Lily O; Al-Din A
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1365-6. PubMed ID: 15314141
    [No Abstract]   [Full Text] [Related]  

  • 5. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence.
    Melo A; Monteiro L
    Parkinsonism Relat Disord; 2013 Mar; 19(3):279-81. PubMed ID: 23231973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factitious disorder mimicking addiction to levodopa in a patient with advanced Parkinson's disease.
    Teixeira-Júnior AL; Cardoso F
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):324-6. PubMed ID: 16100983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.
    Melo A; Monteiro L
    Parkinsonism Relat Disord; 2014 Mar; 20(3):342. PubMed ID: 24300049
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S23-37. PubMed ID: 12211137
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O; von Schéele C
    Pharmacotherapy; 1997; 17(5):1027-30. PubMed ID: 9324193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa.
    Tan A; Salgado M; Fahn S
    Mov Disord; 1996 Mar; 11(2):214-6. PubMed ID: 8684394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease.
    Frey KA
    Ann Neurol; 2001 Mar; 49(3):285-7. PubMed ID: 11261500
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprenyl and levodopa and Parkinson's disease progression.
    Fowler JS; Fazzini E; Volkow ND
    Ann Neurol; 1996 Aug; 40(2):267-8. PubMed ID: 8773616
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease.
    Clarke CE; Moore AP
    Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysphagia in Parkinson's disease is responsive to levodopa.
    Sutton JP
    Parkinsonism Relat Disord; 2013 Mar; 19(3):282-4. PubMed ID: 23333537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa and the progression of Parkinson's disease.
    Walton-Hadlock JL
    N Engl J Med; 2005 Mar; 352(13):1386; author reply 1386. PubMed ID: 15800240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.